EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inflation of Familywise Error Rate in Treatment Efficacy Testing Due to the Reallocation of Significance Levels Based on Safety Data

Akifumi Notsu, Keita Mori

Mathematics · 08.08.2025 · 13 (16) · 2547

DOI: 10.3390/math13162547 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mathematics, online erschienen am 08.08.2025. Verfasst von Akifumi Notsu und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JSPS KAKENHI.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In randomized clinical trials comparing two standard treatments, a two-sided test for efficacy at a significance level α is typically used when neither treatment is expected to be superior at the design stage. This two-sided test comprises two one-sided tests, each conducted at a significance level of α/2. If safety data later suggest that one treatment is not clinically acceptable due to a higher rate of adverse events, investigators may reallocate the α/2 significance level originally assigned to the one-sided efficacy test for that treatment to the other one-sided test. This results in a two-stage procedure. We examine the impact of such reallocation on the familywise error rate (FWER). Using theoretical derivations and simulation studies, we show that FWER can exceed the nominal level α when the treatment with fewer adverse events tends to show greater efficacy. Therefore, the two-stage procedure should be avoided when strict control of FWER is a priority. These findings emphasize the need for caution when reallocating significance levels based on auxiliary information and have implications beyond clinical trials, particularly in adaptive statistical methodologies.

Förderung

  • JSPS KAKENHI

Zitieren

APA

Notsu, A., & Mori, K. (2025). Inflation of Familywise Error Rate in Treatment Efficacy Testing Due to the Reallocation of Significance Levels Based on Safety Data. Mathematics, 13(16), 2547. https://doi.org/10.3390/math13162547

Vancouver

Notsu A, Mori K. Inflation of Familywise Error Rate in Treatment Efficacy Testing Due to the Reallocation of Significance Levels Based on Safety Data. Mathematics. 2025;13(16):2547. doi:10.3390/math13162547

BibTeX
@article{Notsu2025,
  author = {Notsu, Akifumi and Mori, Keita},
  title = {Inflation of Familywise Error Rate in Treatment Efficacy Testing Due to the Reallocation of Significance Levels Based on Safety Data},
  journal = {Mathematics},
  year = {2025},
  volume = {13},
  number = {16},
  pages = {2547},
  doi = {10.3390/math13162547}
}
Kostenlos starten →